IMMUNOMODULATING, METABOLIC AND CARDIOPROTECTIVE EFFECTS OF AT1-ANGIOTENSIN RECEPTORS BLOCKER LOSARTAN IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Teplyakov, A. T. [1 ]
Mayanskaya, S. D. [1 ]
Bolotskaya, L. A. [1 ]
Vdovina, T. V. [1 ]
Stepacheva, T. A. [1 ]
Kuznetsova, A., V [1 ]
Lukinov, A., V [1 ]
Derbeneva, N., V [1 ]
Frants, M., V [1 ]
Shilov, S. N. [1 ]
机构：
[1] Russian Acad Med Sci, State Univ, Sci Res Inst Cardiol, Tomsk Sci Ctr,Siberian Branch, Moscow 109801, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2009年 / 81卷 / 03期
关键词：
RANDOMIZED-TRIAL; CLINICAL STATUS; MORTALITY; ENALAPRIL; INTERVENTION; HYPERTENSION; IRBESARTAN; CAPTOPRIL; SURVIVAL; MODERATE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：62 / 69
页数：8
相关论文
共 50 条
  • [21] Clinical Characteristics and Coronary Angiographic Findings in Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus
    阿玛德
    伍卫
    阿萨德
    王景峰
    聂如琼
    周淑娴
    South China Journal of Cardiology, 2004, (02) : 91 - 96
  • [22] Metabolic syndrome potentiates the risk of coronary heart disease in patients with type 2 diabetes
    Bianchi, C
    Penno, G
    Carciato, F
    Giovannitti, GM
    Malloggi, L
    Pancani, F
    Di Canni, G
    Del Pato, S
    Miccoli, R
    DIABETES, 2005, 54 : A591 - A591
  • [23] Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus
    Lin, Julie
    Hu, Frank B.
    Qi, Lu
    Curhan, Gary C.
    BMC NEPHROLOGY, 2009, 10
  • [24] Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus
    Julie Lin
    Frank B Hu
    Lu Qi
    Gary C Curhan
    BMC Nephrology, 10
  • [25] The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease
    Chaoxin, J.
    Daili, S.
    Yanxin, H.
    Ruwei, G.
    Chenlong, W.
    Yaobin, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) : 2654 - 2659
  • [26] Gender Differences in Risks of Coronary Heart Disease and Stroke in Patients with Type 2 Diabetes Mellitus and Their Association with Metabolic Syndrome in China
    Yao, Mei-Fang
    He, Jie
    Sun, Xue
    Ji, Xiao-Li
    Ding, Yue
    Zhao, Yi-Ming
    Lou, Han-Yu
    Song, Xiao-Xiao
    Shan, Li-Zhen
    Kang, Ying-Xiu
    Zhang, Song-Zhao
    Shan, Peng-Fei
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016
  • [27] The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension
    Kim, Ji Hyun
    Oh, Su Jin
    Lee, Jung Min
    Hong, Eun Gyoung
    Yu, Jae Myung
    Han, Kyung Ah
    Min, Kyung Wan
    Son, Hyun Shik
    Chang, Sang Ah
    DIABETES & METABOLISM JOURNAL, 2011, 35 (03) : 236 - 242
  • [28] Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus
    Ozaki, Nobuaki
    Nomura, Yoshio
    Sobajima, Hiroshi
    Kondo, Kunikazu
    Oiso, Yutaka
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (03) : 236 - 239
  • [29] Characteristics of intestinal flora in female patients with type 2 diabetes mellitus and coronary heart disease
    张爱敏
    China Medical Abstracts(Internal Medicine), 2022, 39 (02) : 89 - 90
  • [30] THE FEATURES OF CEREBRAL HEMODYNAMICS IN PATIENTS WITH CORONARY HEART DISEASE END DIABETES MELLITUS TYPE 2
    Sheludchenko, O.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 154 - 154
12345